| Quarter | Prior | Estimate | Actual | Surprise | |
|---|---|---|---|---|---|
| Q1 2020 After-Hours | EPS: REV: | 0.39 98.023M | |||
| Q4 2019 After-Hours | EPS: REV: | 0.24 73.15M | |||
| Q3 2019 After-Hours | EPS: REV: | 0.7 61.636M | |||
| Q2 2019 After-Hours | EPS: REV: | 3.82 124.824M | |||
| Q1 2019 After-Hours | EPS: REV: | 0.85 55.464M | 0.4 101.2M | 0.39 98.023M | -2.5% -3.14% |
| Q4 2018 After-Hours | EPS: REV: | 0.94 54.321M | 0.24 81.53M | 0.24 73.15M | -10.28% |
| Q3 2018 After-Hours | EPS: REV: | 1.13 55.763M | 66.65M | 0.7 61.636M | -7.52% |
| Q2 2018 After-Hours | EPS: REV: | 3.67 116.136M | 4.15 125.8M | 3.82 124.824M | -7.95% -0.78% |
| Q1 2018 After-Hours | EPS: REV: | 0.33 39.182M | 0.62 52.37M | 0.85 55.464M | 37.1% 5.91% |
| Q4 2017 After-Hours | EPS: REV: | 0.7 39.121M | 0.94 54.321M |
Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!
News Coverage
- No Sauce In Domino's Earnings, But This Chart Is Looking Red
- Dropbox Holds 'Margin Expansion Opportunity,' BofA Says In Upgrade
- The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
- 3 Analysts React To Roku Earnings
- Delphi Beats Quarterly Consensus EPS, Revenue In-Line With Expectations